CCL5 is believed to promote the proliferation and metastasis of bladder cancer through the JAK2/STAT3 signaling pathway (Shen et al., 2023), which might suggest the reliability of finasteride in reducing the occurrence of BCa from the perspective of the immune microenvironment. Here, CCL5 is linked to urinary bladder carcinoma.